Glyceollins, a novel class of soy phytoalexins, inhibit angiogenesis by blocking the VEGF and bFGF signaling pathways

Molecular Nutrition and Food Research

Volumn 57, Issue 2, 2013, Pages 225-234

  Lee, Sun H ^a   Lee, Jongkook ^b   Jung, Myung H ^c   Lee, You M ^a,d  

^a Kyungpook National University   (South Korea)

^b Kangwon National University   (South Korea)

^c Korea Atomic Energy Research Institute   (South Korea)

^d Kyungpook National University   (South Korea)

Author keywords

Angiogenesis inhibitor; BFGF; Glyceollins; Signaling pathway; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYCEOLLIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHYTOALEXINS; PLANT EXTRACT; PTEROCARPAN DERIVATIVE; SESQUITERPENE; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VEGFA PROTEIN, HUMAN;

ANIMAL; ARTICLE; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CHICK EMBRYO; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOYBEAN; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ZEBRA FISH;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHICK EMBRYO; FIBROBLAST GROWTH FACTOR 2; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT EXTRACTS; PTEROCARPANS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SESQUITERPENES; SIGNAL TRANSDUCTION; SOYBEANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; ZEBRAFISH;

GLYCINE MAX;

EID: 84872804317     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200489     Document Type: Article

References (29)

1. Graham, T. L., Graham, M. Y., Glyceollin elicitors induce major but distinctly different shifts in isoflavonoid metabolism in proximal and distal soybean cell populations. Mol. Plant Microbe Interact. 1991, 4, 60-68.
2. Darvill, A. G., Albersheim, P., Phytoalexins and their elicitors: a defense against microbial infections in plants. Annu. Rev. Plant Physiol. 1984, 35, 243-275.
3. Daniel, O., Meier, M. S., Schlatter, J., Frishknect, P., Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides. Environ. Health Perspect. 1999, 107, 109-114.
4. Bhattacharyya, M. K., Ward, E. W. B., Resistance, susceptibility and accumulation of glyceollins I-III in soybean organs inoculated with Phytophthora megasperma f. sp. glycinea. Physiol. Mol. Plant Pathol. 1986, 29, 227-237.
5. Salvo, V. A., Boué, S. M., Fonseca, J. P., Elliott, S. et al., Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin. Cancer Res. 2006, 12, 7159-7164.
6. Burow, M. E., Boue, S. M., Collins-Burow, B. M., Melnik, L. I. et al., Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta. J. Clin. Endocrinol. Metab. 2001, 86, 1750-1758.
7. Song, M. J., Baek, I., Jeon, S. B., Seo, M. et al., Effects of glyceollin I on vascular contraction in rat aorta. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 381, 517-528.
8. Park, S., Ahn, I. S., Kim, J. H., Lee, M. R. et al., Glyceollins, one of the phytoalexins derived from soybeans under fungal stress, enhance insulin sensitivity and exert insulinotropic actions. J. Agric. Food Chem. 2010, 58, 1551-1557.
9. Lee, Y. S., Kim, H. K., Lee, K. J., Jeon, H. W. et al., Inhibitory effect of glyceollin isolated from soybean against melanogenesis in B16 melanoma cells. BMB Rep. 2010, 43, 461-467.
10. Mead, M. N., Mining for glyceollins. Environ. Health Perspect. 2007, 115, A189.
11. Carmeliet, P., Angiogenesis in health and disease. Nat. Med. 2003, 9, 653-660.
12. Maxwell, P. H., Ratcliffe, P. J., Oxygen sensors and angiogenesis. Semin. Cell Dev. Biol. 2002, 13, 29-37.
13. Ferrara, N., The biology of VEGF and its receptors. Nat. Med. 2003, 9, 669-676.
14. Koch, S., Tugues, S., Li, X., Gualandi, L., Claesson-Welsh, L., Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 2011, 437, 169-183.
15. Montesano, R., Vassalli, J.-D., Baird, A., Guillemin, R., Orci, L., Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA 1986, 83, 7297-7301.
16. Boué, S. M., Carter, C. H., Ehrlich, K. C., Cleveland, T. E., Induction of the soybean phytoalexins coumestrol and glyceollin by Aspergillus. J. Agric. Food Chem. 2000, 48, 2167-2172.
17. Meyer, M., Clauss, M., Lepple-Wienhues, A., Augustin, H. G. et al., A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 1999, 182, 363-374.
18. Westerfield, M., The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio). 3rd Edn., University of Oregon Press, Eugene 1995.
19. Eriksson, A., Cao, R., Pawliuk, R., Berg, S. M. et al., Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 2002, 1, 99-108.
20. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H. et al., Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262, 5592-5595.
21. Huang, X., Chen, S., Xu, L., Liu, Y. et al., Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res. 2005, 65, 3470-3478.
22. Gupta, S. C., Kim, J. H., Prasad, S., Aggarwal, B. B., Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010, 29, 405-434.
23. Mousa, A. S., Mousa, S. A., Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53. Nutr. Cancer 2005, 53, 104-110.
24. Kumar, A., D'Souza, S. S., Tickoo, S., Salimath, B. P., Singh, H. B., Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo. Integr. Cancer Ther. 2009, 8, 75-87.
25. Min, J. K., Han, K. Y., Kim, E. C., Kim, Y. M. et al., Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res. 2004, 64, 644-651.
26. Sasamura, H., Takahashi, A., Miyao, N., Yanase, M. et al., Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma. Br. J. Cancer 2002, 86, 768-773.
27. Dell'Eva, R., Ambrosini, C., Minghelli, S., Noonan, D. M. et al., The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway. Carcinogenesis 2007, 28, 404-413.
28. Fang, J. S., Gillies, R. D., Gatenby, R. A., Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin. Cancer Biol. 2008, 18, 330-337.
29. Zimmermann, M. C., Tilghman, S. L., Boué, S. M., Salvo, V. A. et al., Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. J. Pharmacol. Exp. Ther. 2010, 332, 35-45.